Home

precis Retuşare Nautic antagonista receptor kappa opiodes depresion Narabar Rafflesia Arnoldi Curățați dormitorul

Endogenous opioid system dysregulation in depression: implications for new  therapeutic approaches | Molecular Psychiatry
Endogenous opioid system dysregulation in depression: implications for new therapeutic approaches | Molecular Psychiatry

Frontiers | A Review of the Therapeutic Potential of Recently Developed G  Protein-Biased Kappa Agonists
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists

Cognitive System and opioid receptor expression in the rat brain.... |  Download Scientific Diagram
Cognitive System and opioid receptor expression in the rat brain.... | Download Scientific Diagram

Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and  Back
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back

Kappa opioid receptor (KOR) modulation of dopamine in the cortex and... |  Download Scientific Diagram
Kappa opioid receptor (KOR) modulation of dopamine in the cortex and... | Download Scientific Diagram

Dynorphin/kappa-opioid receptor control of dopamine dynamics: Implications  for negative affective states and psychiatric disorders - ScienceDirect
Dynorphin/kappa-opioid receptor control of dopamine dynamics: Implications for negative affective states and psychiatric disorders - ScienceDirect

Chronic Kappa opioid receptor activation modulates NR2B: Implication in  treatment resistant depression | Scientific Reports
Chronic Kappa opioid receptor activation modulates NR2B: Implication in treatment resistant depression | Scientific Reports

Kappa opioid receptor signaling in the brain: Circuitry and implications  for treatment - ScienceDirect
Kappa opioid receptor signaling in the brain: Circuitry and implications for treatment - ScienceDirect

Kappa Opioid Receptor Ligands and Pharmacology: Diphenethylamines, a Class  of Structurally Distinct, Selective Kappa Opioid Ligands | SpringerLink
Kappa Opioid Receptor Ligands and Pharmacology: Diphenethylamines, a Class of Structurally Distinct, Selective Kappa Opioid Ligands | SpringerLink

Development of κ Opioid Receptor Antagonists | Journal of Medicinal  Chemistry
Development of κ Opioid Receptor Antagonists | Journal of Medicinal Chemistry

Pharmaceuticals | Free Full-Text | Therapeutic Potential of Kappa Opioid  Agonists
Pharmaceuticals | Free Full-Text | Therapeutic Potential of Kappa Opioid Agonists

Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes  for the Kappa Opioid Receptor | Journal of Medicinal Chemistry
Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry

Opioid Receptors Mnemonic | Epomedicine
Opioid Receptors Mnemonic | Epomedicine

Psychoactives | Free Full-Text | The Role of the Dynorphin/Kappa Opioid  Receptor System in the Actions of Alcohol
Psychoactives | Free Full-Text | The Role of the Dynorphin/Kappa Opioid Receptor System in the Actions of Alcohol

Opioid receptors: distinct roles in mood disorders: Trends in Neurosciences
Opioid receptors: distinct roles in mood disorders: Trends in Neurosciences

Biased agonists of the kappa opioid receptor suppress pain and itch without  causing sedation or dysphoria | Science Signaling
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling

The Impact of Opioid Analgesics and the Pharmacogenomics of ABCB1 in Opioid  Dependence and Pharmacotherapies: A Short Review
The Impact of Opioid Analgesics and the Pharmacogenomics of ABCB1 in Opioid Dependence and Pharmacotherapies: A Short Review

Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands:  Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience

Pharmaceuticals | Free Full-Text | Biased, Bitopic, Opioid–Adrenergic  Tethered Compounds May Improve Specificity, Lower Dosage and Enhance  Agonist or Antagonist Function with Reduced Risk of Tolerance and Addiction
Pharmaceuticals | Free Full-Text | Biased, Bitopic, Opioid–Adrenergic Tethered Compounds May Improve Specificity, Lower Dosage and Enhance Agonist or Antagonist Function with Reduced Risk of Tolerance and Addiction

Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and  Back
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back

Molecules | Free Full-Text | Design of κ-Opioid Receptor Agonists for  the Development of Potential Treatments of Pain with Reduced Side Effects
Molecules | Free Full-Text | Design of κ-Opioid Receptor Agonists for the Development of Potential Treatments of Pain with Reduced Side Effects

Major Depressive Disorder and Kappa Opioid Receptor
Major Depressive Disorder and Kappa Opioid Receptor

Critical Assessment of G Protein-Biased Agonism at the μ-Opioid Receptor:  Trends in Pharmacological Sciences
Critical Assessment of G Protein-Biased Agonism at the μ-Opioid Receptor: Trends in Pharmacological Sciences

Kappa Opioid Receptors in the Pathology and Treatment of Major Depressive  Disorder | SpringerLink
Kappa Opioid Receptors in the Pathology and Treatment of Major Depressive Disorder | SpringerLink

Frontiers | The Role of the Kappa Opioid System in Comorbid Pain and  Psychiatric Disorders: Function and Implications
Frontiers | The Role of the Kappa Opioid System in Comorbid Pain and Psychiatric Disorders: Function and Implications

A systematic review on the kappa opioid receptor and its ligands: New  directions for the treatment of pain, anxiety, depression, and drug abuse -  ScienceDirect
A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect

Opioids in cancer: The κ‑opioid receptor (Review)
Opioids in cancer: The κ‑opioid receptor (Review)